Journal of Cancer Therapy
Vol.4 No.10A(2013), Paper ID 39562, 6
pages
DOI:10.4236/jct.2013.410A004
Pancreatic Neuroendocrine Tumors Are Characterized by Loss of Noxa Expression that Can be Recovered by the Proteasome Inhibitor Bortezomib
E. P. Slater, J. Waldmann, C. López, E. Matthäi, V. Fendrich, D. K. Bartsch
Department of Surgery, Philipps University, Marburg, Germany
Department of Surgery, Philipps University, Marburg, Germany
Department of Surgery, Philipps University, Marburg, Germany
Department of Surgery, Philipps University, Marburg, Germany
Department of Surgery, Philipps University, Marburg, Germany
Department of Surgery, Philipps University, Marburg, Germany
Copyright © 2013 E. P. Slater, J. Waldmann, C. López, E. Matthäi, V. Fendrich, D. K. Bartsch et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
E. Slater, J. Waldmann, C. López, E. Matthäi, V. Fendrich and D. Bartsch, "Pancreatic Neuroendocrine Tumors Are Characterized by Loss of
Noxa Expression that Can be Recovered by the Proteasome Inhibitor Bortezomib,"
Journal of Cancer Therapy, Vol. 4 No. 10A, 2013, pp. 28-33. doi:
10.4236/jct.2013.410A004.